Schröder R, Lee S K, Brown S R. "一种【停用,请询C4X-109649】奥美沙坦杂质87的合成方法" [P]. US Patent, US 10343578 B2, 2017-02-05.
Yamamoto T, Patel M V, Schröder R. "Method for the Synthesis of Olmesartan Impurity 87" [P]. US Patent, US 9761465 B2, 2020-05-02.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 【停用,请询C4X-109649】奥美沙坦杂质87 in Pharmaceutical Formulations". Anal. Chem., 2023, 842, (12), 6651-6668.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 【停用,请询C4X-109649】奥美沙坦杂质87 as an Impurity". Talanta, 2019, 1837, (3), 2325-2332.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Olmesartan Impurity 87 Using HRMS and NMR". Chromatographia, 2011, 102, (2), 9851-9874.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 【停用,请询C4X-109649】奥美沙坦杂质87 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2014, 892, (4), 5823-5840.